Margarida Maia, PhD, science writer —

Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.

Articles by Margarida Maia

APDA awards $2.6M to support Parkinson’s research projects

The American Parkinson Disease Association (APDA) has awarded a total of $2.6 million for the 2024-2025 funding year, to support a range of research projects that aim to advance understanding of Parkinson’s disease. The nationwide grassroots network increased its funding package by more than 30% over last year,…

FDA letter supports use of new alpha-synuclein assay in trials

The U.S. Food and Drug Administration (FDA) is encouraging scientists and drug developers to use an alpha-synuclein seed amplification assay (synSAA) to improve the development and efficiency of clinical trials seeking to delay or prevent the development of Parkinson’s and other neurodegenerative diseases that share toxic clumps of that protein…

Cycling better than electrical muscle stimulation for cognition: Study

Cycling was more effective than electrical muscle stimulation at improving cognitive function, according to a small study. The results have implications for neurodegenerative diseases like Parkinson’s in which both movement and cognition can be affected. “Our results suggest that the relationship between exercise and brain activity is crucial for faster…